PAQR6 and neoplasm: Similarly, PFS, assessed using the GSE29609 dataset (Figure 1G), evaluates the time to disease progression, including tumor recurrence or metastasis, offering critical insights into whether elevated PAQR6 expression is linked to more aggressive disease behavior or shorter recurrence-free intervals.